Abstract
Background: The risk of life-threatening complications, such as visceral disseminated varicella zoster virus (VZV) infection, is greater in immunosuppressed individuals, such as systemic lupus erythematosus (SLE) patients. Case presentation: Here, a case is reported of a Caucasian woman diagnosed with lupus nephritis and anti-phospholipid syndrome, who was subjected to mycophenolate mofetil and high-dose steroid remission-induction therapy. Two months later she developed abdominal pain followed by a fatal rapid multi-organ failure. As no typical skin rashes were evident, death was initially attributed to catastrophic anti-phospholipid syndrome. However, autopsy and virological examinations on archival material revealed a disseminated VZV infection. Conclusions: Overall, this case highlights the importance of having a high clinical suspicion of fatal VZV infections in heavily immunosuppressed SLE patients even when typical signs and symptoms are lacking.
| Original language | English |
|---|---|
| Article number | 538 |
| Journal | BMC Infectious Diseases |
| Volume | 20 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 23 Jul 2020 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Herpesviruses
- Immunosuppression
- Latent virus infections
- Multiple virus reactivations
- Mycophenolate mofetil
- Steroid therapy
- Systemic lupus erythematosus
- Varicella zoster virus
Fingerprint
Dive into the research topics of 'Unusual presentation of fatal disseminated varicella zoster virus infection in a patient with lupus nephritis: A case report'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver